Therefore, inclusion of multiple epitopes, including ICD-specific epitopes, in HER2 antigen might improve the efficacy of anti-HER2 cancer vaccines as a combination therapy for checkpoint blockade. This evidence concerns the gene ERBB2 and cancer.